Lynn D. Wilson, MD, MPH, Appointed Deputy Chief Medical Officer for Radiation Oncology
We are pleased to announce the appointment of Lynn D. Wilson, MD, MPH, to Deputy Chief Medical Officer for Radiation Oncology for Smilow Cancer Hospital and our Smilow Cancer Hospital Network. Dr. Wilson’s established leadership in the Department of Therapeutic Radiology and dedication to the success of our radiation oncology program has led to enhanced, innovative care for our patients and a steadfast focus on excellence. In his new role, Dr. Wilson will partner with our Smilow leadership team to ensure multidisciplinary treatment is available to all patients and coordinated radiation oncology treatment is accessible throughout our Smilow Cancer Hospital Network.
A Professor of Therapeutic Radiology and Dermatology at Yale School of Medicine, Dr. Wilson specializes in treating patients with cutaneous lymphoma and breast cancer. In addition, he serves as Executive Vice Chairman and Director of Clinical Affairs for the Department of Therapeutic Radiology. He was the inaugural recipient of the David J. Leffell, MD Prize for Clinical Excellence and is a past recipient of the Francis Gilman Blake Award for teaching at Yale School of Medicine. In 2011, he was named a Fellow of the American Society for Radiation Oncology (FASTRO).
Dr. Wilson is a graduate of Denison University and earned his master’s in public health in health services administration from Yale School of Public Health before obtaining his medical degree at George Washington University School of Medicine. He completed his residency at Yale New Haven Hospital and served as Chief Resident before joining the faculty in 1994.
Please join us in thanking James B. Yu, MD, MHS, for his leadership and service to Smilow Cancer Hospital in the position of Associate Chief Medical Officer for Radiation Oncology over the last year. Dr. Yu has announced that he will be leaving Yale School of Medicine and Smilow Cancer Hospital at the end of the year to pursue another career opportunity. We wish Dr. Yu all the best in his next endeavors, and look forward to working closely with Dr. Wilson in his new leadership role.